Clinical trial
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage…
NCT00002774 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00002774 |
|---|---|
| Title | Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer |
| Official title | Randomized Phase 2 Trial of Tirapazamine and the Role of Tumor Hypoxia in Advanced Squamous Head and Neck Cancer |
| Lead sponsor | Stanford University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Squamous Neck Carcinoma of the Head and Neck Cancer (SCCHN) |
| Intervention type | Drug, Radiation |
| Interventions | Tirapazamine, Cisplatin, 5-fluorouracil, Radiotherapy (RT) |
| Enrollment | 63 |
| Start date | Jun 1, 1996 |
| Primary completion | Jun 1, 2000 |
| Completion | Jun 1, 2005 |
| First posted | Apr 6, 2004 |
| Last update posted | Jun 20, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: